Precigenetics
Tracked across 2 events · 14 articles · First seen Aug 08, 2026 · Last active Sep 15, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Precigenetics is the central innovator, developing the live-cell observation platform and related technologies, positioning it for growth in the biotech market.
Aug 08, 2026 · 6 articles
Business
GSK plc announced on September 15, 2026 that it has entered an agreement to acquire a potential best-in-class trispecific T cell-engager (TCE) for multiple myeloma from privately held clinical-stage biotechnology firm Chimagen Biosciences. The agreement…
Impact: Precigenetics is mentioned only as a better-ranked biotech stock in the sector comparison, with no direct role in the GSK-Chimagen transaction.
Sep 15, 2026 · 8 articles
ERGEN INTELLIGENCE
Track Precigenetics live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard